510(k) K051072
K051072 is an FDA 510(k) premarket notification submitted by Bio-Rad Laboratories, Inc. for the device "BIO-RAD VARIANT NBS SICKLE CELL PROGRAM". The FDA issued a decision of Substantially Equivalent on May 12, 2005. The device falls under product code GKA (Abnormal Hemoglobin Quantitation), a Class II device regulated under 21 CFR 864.7415. Bio-Rad Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 12, 2005
- Date Received
- April 26, 2005
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- Yes
Device Classification
- Device Name
- Abnormal Hemoglobin Quantitation
- Device Class
- Class II
- Regulation Number
- 864.7415
- Review Panel
- HE
- Submission Type